At A Glance: This Prescriber in 2011
Self-Reported Primary Specialty
Rank: 15 out of 37
Rank: 20 out of 37
How Does This Prescriber Compare to Peers?
in Rhode Island
Antipsychotics to Seniors
Dangerous Drugs to Seniors
Brand Name Drugs
44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.
$153 was the average price of a prescription from this provider, compared to $160 among peers.
Prescriptions per Patient
10 is the average number of prescriptions (including refills) per patient, compared to an average of 11.
This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.
KEY: How to read this
Hover to see more prescribers
This Prescriber's Drugs
Search for a Drug
5 questions to ask about a new drug »
via Consumer Health Choices
Compare different prescription drugs »
via Consumer Reports
Click to Filter by Category
A narcotic drug. More » Misuse and abuse of narcotics led to some 16,000 overdose deaths in 2010.
This provider is among the top 10 prescribers of
this drug in the country.
This Drug's Rank
Total Prescriptions Filled
|Category||For this Prescriber||
For All Prescribers in
This Specialty in Rhode Island
Donepezil is used to treat ... +
Donepezil is used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) associated with Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Donepezil is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory, attention, social interaction, reasoning and language abilities, and ability to perform activities of daily living) by increasing the amount of a certain naturally occurring substance in the brain. Donepezil may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, donepezil will not cure AD or prevent the loss of mental abilities at some time in the future. More info »
Treats dementia (memory los... +
Treats dementia (memory loss and mental changes) that is a sign of Alzheimer's disease. More info »
Rivastigmine is used to tre... +
Rivastigmine is used to treat mild to moderate dementia (memory loss) associated with Alzheimer's disease or Parkinson's disease. More info »
Treats severe depression an... +
Treats severe depression and generalized anxiety disorder (GAD). This medicine is a selective serotonin reuptake inhibitor (SSRI). More info »
Citalopram is used to treat... +
Citalopram is used to treat depression. Citalopram is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It is thought to work by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance. More info »
Galantamine is used to trea... +
Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future. More info »
Treats symptoms of Alzheime... +
Treats symptoms of Alzheimer's disease such as confusion or dementia (memory loss and mental changes). More info »
About This Data
- No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
- This provider's address and specialty information was last updated on May 20, 2008.